RIL
GSK icon

Rothschild Investment LLC’s GSK GSK Stock Holding History

Rothschild Investment LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689K Buy
13,146
+25
+0.2% +$1.32K 0.03% 506
2026
Q1 		$724K Buy
13,121
+25
+0.2% +$1.35K 0.04% 325
2025
Q4 		$642K Sell
13,096
-900
-6% -$42K 0.04% 312
2025
Q3 		$604K Buy
13,996
+1,134
+9% +$44.3K 0.03% 312
2025
Q2 		$494K Buy
12,862
+590
+5% +$22.5K 0.03% 342
2025
Q1 		$475K Buy
12,272
+396
+3% +$14.5K 0.03% 346
2024
Q4 		$402K Sell
11,876
-5,140
-30% -$185K 0.03% 385
2024
Q3 		$696K Sell
17,016
-860
-5% -$35.2K 0.05% 294
2024
Q2 		$688K Buy
17,876
+391
+2% +$16.4K 0.05% 285
2024
Q1 		$750K Buy
17,485
+54
+0.3% +$2.23K 0.05% 271
2023
Q4 		$646K Sell
17,431
-1,413
-7% -$50.7K 0.05% 249
2023
Q3 		$683K Sell
18,844
-64
-0.3% -$2.27K 0.06% 262
2023
Q2 		$674K Buy
18,908
+983
+5% +$35.3K 0.06% 268
2023
Q1 		$638K Sell
17,925
-715
-4% -$25K 0.06% 271
2022
Q4 		$655K Sell
18,640
-12,000
-39% -$400K 0.06% 252
2022
Q3 		$902K Sell
30,640
-2,400
-7% -$91K 0.09% 216
2022
Q2 		$1.8M Sell
33,040
-5,200
-14% -$287K 0.17% 132
2022
Q1 		$2.08M Hold
38,240
– – 0.16% 132
2021
Q4 		$2.11M Buy
38,240
+14,480
+61% +$753K 0.16% 131
2021
Q3 		$1.14M Sell
23,760
-1,026
-4% -$51.5K 0.1% 206
2021
Q2 		$1.23M Sell
24,786
-1,600
-6% -$76.9K 0.1% 193
2021
Q1 		$1.18M Sell
26,386
-1,600
-6% -$72.6K 0.1% 199
2020
Q4 		$1.29M Sell
27,986
-62
-0.2% -$2.85K 0.12% 165
2020
Q3 		$1.32M Sell
28,048
-800
-3% -$40.1K 0.14% 141
2020
Q2 		$1.47M Sell
28,848
-578
-2% -$29.7K 0.18% 127
2020
Q1 		$1.39M Sell
29,426
-240
-0.8% -$12.8K 0.18% 128
2019
Q4 		$1.74M Hold
29,666
– – 0.17% 135
2019
Q3 		$1.58M Sell
29,666
-80
-0.3% -$4.12K 0.18% 125
2019
Q2 		$1.49M Sell
29,746
-547
-2% -$27.4K 0.18% 131
2019
Q1 		$1.58M Hold
30,293
– – 0.19% 129
2018
Q4 		$1.45M Hold
30,293
– – 0.19% 125
2018
Q3 		$1.52M Hold
30,293
– – 0.18% 128
2018
Q2 		$1.53M Sell
30,293
-2,946
-9% -$148K 0.19% 124
2018
Q1 		$1.62M Buy
33,239
+13,440
+68% +$626K 0.21% 119
2017
Q4 		$878K Sell
19,799
-1,419
-7% -$65.6K 0.1% 208
2017
Q3 		$1.08M Sell
21,218
-1,651
-7% -$83.8K 0.12% 190
2017
Q2 		$1.23M Hold
22,869
– – 0.14% 179
2017
Q1 		$1.21M Sell
22,869
-12,472
-35% -$633K 0.14% 181
2016
Q4 		$1.7M Buy
35,341
+8,506
+32% +$420K 0.2% 128
2016
Q3 		$1.45M Sell
26,835
-1,535
-5% -$84.2K 0.18% 139
2016
Q2 		$1.54M Buy
28,370
+80
+0.3% +$4.21K 0.2% 126
2016
Q1 		$1.43M Buy
28,290
+823
+3% +$41K 0.18% 131
2015
Q4 		$1.39M Buy
27,467
+1,920
+8% +$97.9K 0.18% 138
2015
Q3 		$1.23M Buy
25,547
+1,120
+5% +$58.3K 0.16% 147
2015
Q2 		$1.27M Buy
24,427
+1,034
+4% +$58.2K 0.15% 166
2015
Q1 		$1.35M Sell
23,393
-2,900
-11% -$166K 0.16% 148
2014
Q4 		$1.41M Buy
26,293
+1,591
+6% +$89K 0.17% 135
2014
Q3 		$1.42M Sell
24,702
-312
-1% -$19.1K 0.17% 137
2014
Q2 		$1.67M Buy
25,014
+84
+0.3% +$5.69K 0.21% 118
2014
Q1 		$1.67M Buy
24,930
+88
+0.4% +$5.95K 0.22% 110
2013
Q4 		$1.66M Buy
24,842
+160
+0.6% +$10.4K 0.23% 104
2013
Q3 		$1.55M Buy
24,682
+280
+1% +$18K 0.23% 104
2013
Q2 		$1.52M Buy
+24,402
New +$1.55M 0.25% 100

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Rothschild Investment LLC's GSK Position: Q2 2026 in Review

Rothschild Investment LLC increased its GSK (GSK) stake by 0.19% in Q2 2026, buying an estimated $1.32K and bringing the position to 13,146 shares worth $689K. The position accounts for 0.03% of the portfolio, ranked #506.

Rothschild Investment LLC first reported a position in GSK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.11M in Q4 2021. 582 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Rothschild Investment LLC held 13,146 shares of GSK worth $689K as of Q2 2026.
  • Rothschild Investment LLC bought 25 GSK shares in Q2 2026, an estimated $1.32K.
  • GSK made up 0.03% of Rothschild Investment LLC's portfolio in Q2 2026, its #506 holding.
  • Rothschild Investment LLC first reported a position in GSK in Q2 2013 and has held it in 53 quarters since.
  • Rothschild Investment LLC's GSK position peaked at $2.11M in Q4 2021.
  • 582 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.